We study the effects of unparticle physics in the pair productions of top quarks at the LHC and ILC. By considering vector, tensor and scalar unparticle operators, as appropriate, we compute the total cross sections for pair production processes depending on scale dimension d U . We find that the existence of unparticles would lead to measurable enhancements on the SM predictions at the LHC. In the case of ILC this may become two orders of magnitude larger than that of SM, for smaller values of d U , a very striking signal for unparticles.
It is shown that "right" sneutrino can be the lightest supersymmetric particle. Clearly, this possibility will drastically change decay chains of SUSY particles. The sneutrino production at next linear colliders has been analyzed in this scenario.
We study the single production of top quarks in e + e − , ep and pp collisions in the context of unparticle physics through the Flavor Violating (FV) unparticle vertices and compute the total cross sections for single top production as functions of scale dimension d U . We find that among all, LHC is the most promising facility to probe the unparticle physics via single top quark production processes.
We study the single top production mediated by flavor changing neutral current via both of the t − q − γ and t − q − Z vertices (here q represents c and u quarks) in ep collisions at two colliders HERA and THERA. Contribution of the second vertex becomes even more important as the couplings take more improved values provided by the higher luminosities of colliders. In addition to these improvements if the CM energy of the collider is increased, the production will be dominated by the anomalous t − q − Z vertex.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.